Cargando…
Chronic active Epstein-Barr virus infection treated with PEG-aspargase: A case report
BACKGROUND: Chronic active Epstein-Barr virus infection (EBV) is a systemic EBV-positive lymphoproliferative disease, which may lead to fatal illness. There is currently no standard treatment regimen for chronic active EBV (CAEBV), and hematopoietic stem cell transplantation is the only effective tr...
Autores principales: | Song, De-Li, Wang, Jing-Shi, Chen, Lei-Lei, Wang, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462253/ https://www.ncbi.nlm.nih.gov/pubmed/34621836 http://dx.doi.org/10.12998/wjcc.v9.i26.7845 |
Ejemplares similares
-
PEG-aspargase and DEP regimen combination therapy for refractory Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis
por: Wang, Jingshi, et al.
Publicado: (2016) -
Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
por: Chen, Ruyue, et al.
Publicado: (2023) -
Kidney involvement of chronic active Epstein‐Barr virus infection
por: Fukumoto, Ami, et al.
Publicado: (2023) -
Chronic Active Epstein–Barr Virus Disease
por: Kimura, Hiroshi, et al.
Publicado: (2017) -
Ruxolitinib in Patients With Chronic Active Epstein-Barr Virus Infection: A Retrospective, Single-Center Study
por: Song, Yue, et al.
Publicado: (2021)